Loading organizations...
Based in Oakland, California, AnimalBiome is a pet health technology company that provides at-home microbiome testing kits and restorative supplements for dogs and cats. The enterprise utilizes genetic sequencing to analyze gut bacteria and distributes personalized nutrition products, including oral fecal microbiota transplant capsules, directly to consumers and wholesale to veterinary clinics. Operating with approximately 60 employees, the business generates an estimated $16.4 million in revenue and has analyzed tens of thousands of companion animal samples to build its microbiome database. The company has secured over $10 million in total funding, including an $8.6 million Series A round led by Arthur Ventures, with additional backing from SOSV, Leap Venture Studio, and the IndieBio accelerator. AnimalBiome was founded in 2016 by Holly Ganz and Carlton Osborne as a spin-off from academic research conducted at UC Davis.
AnimalBiome has raised $14.3M across 6 funding rounds.
AnimalBiome has raised $14.3M in total across 6 funding rounds.
AnimalBiome has raised $14.3M in total across 6 funding rounds.
AnimalBiome's investors include Cargill, Emergence Capital, Richard Branson, Digitalis Ventures, Michelson Found Animals Foundation, Moai Capital, R/GA Ventures, SOSV, Ataria Ventures, Mayfield, Social Impact Capital, Justin Mateen.
AnimalBiome has raised $14.3M across 6 funding rounds. Most recently, it raised $9.0M Series A in June 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2021 | $9M Series A | Cargill | Emergence Capital, Richard Branson, Digitalis Ventures, Michelson Found Animals Foundation, Moai Capital, R/GA Ventures, SOSV | Announced |
| Jul 1, 2020 | $1M Seed | — | Ataria Ventures, Emergence Capital, Mayfield, Social Impact Capital, SOSV, Justin Mateen, Richard Branson | Announced |
| Feb 12, 2020 | $1.5M Seed | — | — | Announced |
| Feb 1, 2019 | $2M Seed | — | Emergence Capital, Richard Branson | Announced |
| Aug 1, 2018 | $600K Seed | — | Ataria Ventures, Mayfield, Social Impact Capital, SOSV, Justin Mateen | Announced |
| Oct 1, 2016 | $250K Seed | — | Ataria Ventures, Mayfield, Social Impact Capital, SOSV, Justin Mateen | Announced |
AnimalBiome is a pet health technology company founded in 2016 that specializes in microbiome science for companion animals, particularly cats and dogs. It offers gut health testing kits, personalized supplements, and therapeutics to address chronic digestive issues like diarrhea, vomiting, and constipation, affecting over 9 million pets in the US.[1][2][3] The company serves pet parents and veterinarians by analyzing fecal samples against the world's largest database of healthy pet microbiomes, providing actionable reports with diet and supplement recommendations to restore balance and prevent conditions related to gut dysbiosis.[1][4] With $12.3M in funding to date, including a $1.5M seed round, AnimalBiome has shown growth through accelerators like IndieBio and Leap, partnerships with organizations like Morris Animal Foundation and Hill's, and plans for microbial cocktails, positioning it as a leader in pet microbiome solutions.[2][4][5][8]
AnimalBiome emerged from research by co-founder Holly Ganz at UC Davis School of Veterinary Medicine and Genome Center, inspired by her herding dog's battle with hemorrhagic gastroenteritis (HGE), a severe gut condition triggered by diet.[3][5] Launched via a successful 2015 Kickstarter and first products in 2016, the company was co-founded by scientists from UC Davis and Berkeley, with Ganz as Chief Science Officer and Carlton Osborne as CEO.[1][4] Early traction came from IndieBio's 2017 accelerator, Leap Venture Studio in 2018, and building the largest microbiome database for carnivores (cats and dogs), enabling diagnostics, probiotics, and a patent-pending room-temperature stable fecal microbiota transplant pill with over 90% efficacy in reducing symptoms.[2][4][5]
AnimalBiome rides the pet tech boom intersecting human microbiome advances (e.g., gut bacteria for health) with the $100B+ pet industry, where over half of cats and dogs face microbiome-related issues amid rising pet humanization and premium care spending.[1][2][7] Timing aligns with post-2010s human gut research spillover to vets, accelerated by COVID-driven pet adoptions and demand for science-backed wellness over traditional treatments.[8] Market forces like antibiotic resistance and chronic disease prevalence favor its non-invasive, data-driven alternatives; it influences the ecosystem by donating to shelters, funding studies (e.g., golden retriever cancer biomarkers), and partnering with pharma/nutrition giants, advancing diagnostics and therapeutics for companion animals.[1][6][8]
AnimalBiome is poised to scale with a Series B close, microbial discovery lab launches, and first microbial cocktails for pets by late 2026, expanding beyond supplements to targeted therapies amid growing vet adoption.[5] Trends like AI-enhanced microbiome analysis, personalized pet nutrition, and regulatory nods for animal probiotics will propel it, potentially capturing a slice of the exploding $10B+ pet health market. Its influence may evolve from testing pioneer to ecosystem shaper, partnering deeper with vets and big pet food players to normalize microbiome care—unlocking longer, healthier lives for family pets, much like its Kickstarter roots promised.
